title: Effects of Peptide on NK cell-mediated MHC I recognition.
abstract: The inhibitory receptors for MHC class I have a central role in controlling natural killer (NK) cell activity. Soon after their discovery, it was found that these receptors have a degree of peptide selectivity. Such peptide selectivity has been demonstrated for all inhibitory killer cell immunoglobulin-like receptor (KIR) tested to date, certain activating KIR, and also members of the C-type lectin-like family of receptors. This selectivity is much broader than the peptide specificity of T cell receptors, with NK cell receptors recognizing peptide motifs, rather than individual peptides. Inhibitory receptors on NK cells can survey the peptide:MHC complexes expressed on the surface of target cells, therefore subsequent transduction of an inhibitory signal depends on the overall peptide content of these MHC class I complexes. Functionally, KIR-expressing NK cells have been shown to be unexpectedly sensitive to changes in the peptide content of MHC class I, as peptide:MHC class I complexes that weakly engage KIR can antagonize the inhibitory signals generated by engagement of stronger KIR-binding peptide:MHC class I complexes. This property provides KIR-expressing NK cells with the potential to recognize changes in the peptide:MHC class I repertoire, which may occur during viral infections and tumorigenesis. By contrast, in the presence of HLA class I leader peptides, virus-derived peptides can induce a synergistic inhibition of CD94:NKG2A-expressing NK cells through recruitment of CD94 in the absence of NKG2A. On the other hand, CD94:NKG2A-positive NK cells can be exquisitely sensitive to changes in the levels of MHC class I. Peptide antagonism and sensitivity to changes in MHC class I levels are properties that distinguish KIR and CD94:NKG2A. The subtle difference in the properties of NK cells expressing these receptors provides a rationale for having complementary inhibitory receptor systems for MHC class I.
authors.affiliation: Division of Medicine, Imperial College London , London , UK.
authors.forename: Sorcha A
authors.initials: SA
authors.lastname: Cassidy
authors.affiliation: Division of Medicine, Imperial College London , London , UK.
authors.forename: Kuldeep S
authors.initials: KS
authors.lastname: Cheent
authors.affiliation: Clinical and Experimental Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton , Southampton , UK.
authors.forename: Salim I
authors.initials: SI
authors.lastname: Khakoo
keywords: CD94; KIR; MHC class I; NKG2A; antagonism; natural killer cells; peptides; synergy
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204
references.pmid: 9560253
references.citation: J Immunol. 2001 Nov 1;167(9):4801-4
references.pmid: 11673482
references.citation: J Virol. 2007 Jul;81(13):7220-9
references.pmid: 17459927
references.citation: J Immunol. 2008 Mar 15;180(6):3969-79
references.pmid: 18322206
references.citation: Nature. 2011 Aug 03;476(7358):96-100
references.pmid: 21814282
references.citation: J Immunol. 1995 Nov 1;155(9):4143-6
references.pmid: 7594568
references.citation: Science. 2000 Feb 11;287(5455):1031
references.pmid: 10669413
references.citation: Cell Mol Life Sci. 2011 Nov;68(21):3457-67
references.pmid: 21861183
references.citation: Annu Rev Immunol. 2002;20:217-51
references.pmid: 11861603
references.citation: Immunol Rev. 2009 Mar;228(1):342-59
references.pmid: 19290938
references.citation: Nat Immunol. 2001 May;2(5):452-60
references.pmid: 11323700
references.citation: Nature. 2011 Oct 23;479(7373):401-5
references.pmid: 22020283
references.citation: Nature. 2000 Jun 1;405(6786):537-43
references.pmid: 10850706
references.citation: Mol Cell Proteomics. 2013 Mar;12(3):638-50
references.pmid: 23242552
references.citation: Blood. 2011 Jan 6;117(1):98-107
references.pmid: 20935255
references.citation: Science. 1995 Feb 17;267(5200):1016-8
references.pmid: 7863326
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):E323-31
references.pmid: 21670269
references.citation: Science. 1992 Mar 6;255(5049):1264-6
references.pmid: 1546329
references.citation: Mol Immunol. 2002 May;38(14):1007-21
references.pmid: 11955593
references.citation: Mol Immunol. 2013 Sep;55(2):113-6
references.pmid: 23183105
references.citation: Antivir Ther. 2005;10(1):95-107
references.pmid: 15751767
references.citation: J Immunol. 1998 Aug 1;161(3):1299-305
references.pmid: 9686591
references.citation: J Immunol. 1998 Jul 15;161(2):571-7
references.pmid: 9670929
references.citation: Nature. 1998 Feb 19;391(6669):795-9
references.pmid: 9486650
references.citation: Nat Rev Immunol. 2009 Jul;9(7):503-13
references.pmid: 19498380
references.citation: Immunol Today. 1990 Jul;11(7):237-44
references.pmid: 2201309
references.citation: Am J Pathol. 2005 Feb;166(2):443-53
references.pmid: 15681828
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14326-31
references.pmid: 9826699
references.citation: J Exp Med. 1998 Nov 16;188(10):1841-8
references.pmid: 9815261
references.citation: Blood. 2009 Mar 26;113(13):3119-29
references.pmid: 18945967
references.citation: Nat Rev Immunol. 2011 Nov 11;11(12):823-36
references.pmid: 22076556
references.citation: Proc Natl Acad Sci U S A. 2012 May 1;109(18):7025-30
references.pmid: 22509014
references.citation: J Biol Chem. 2013 Mar 22;288(12):8679-8690
references.pmid: 23335510
references.citation: J Mol Biol. 2008 Apr 11;377(5):1297-303
references.pmid: 18339401
references.citation: J Exp Med. 1996 Aug 1;184(2):735-40
references.pmid: 8760827
references.citation: Nat Rev Immunol. 2006 Jul;6(7):520-31
references.pmid: 16799471
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3864-9
references.pmid: 10097129
references.citation: J Exp Med. 2000 Sep 4;192(5):613-24
references.pmid: 10974028
references.citation: J Immunol. 2012 Nov 1;189(9):4338-48
references.pmid: 23041569
references.citation: Eur J Immunol. 2004 Jun;34(6):1673-9
references.pmid: 15162437
references.citation: J Exp Med. 2002 Oct 7;196(7):911-21
references.pmid: 12370253
references.citation: J Immunol. 2004 Nov 1;173(9):5617-25
references.pmid: 15494512
references.citation: Mol Immunol. 2013 Jan;53(1-2):126-31
references.pmid: 22898188
references.citation: Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16981-6
references.pmid: 24082146
references.citation: J Immunol. 1996 Dec 15;157(12):5367-74
references.pmid: 8955184
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4604-9
references.pmid: 9114037
references.citation: J Exp Med. 1997 Feb 17;185(4):795-800
references.pmid: 9034158
references.citation: J Biol Chem. 1999 Oct 1;274(40):28329-34
references.pmid: 10497191
references.citation: Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6313-8
references.pmid: 9177214
references.citation: J Immunol. 2003 Mar 15;170(6):2977-84
references.pmid: 12626550
references.citation: Eur J Immunol. 1997 May;27(5):1164-9
references.pmid: 9174606
references.citation: J Immunol. 1996 Oct 15;157(8):3350-6
references.pmid: 8871631
references.citation: Eur J Immunol. 2000 Apr;30(4):1172-81
references.pmid: 10760807
references.citation: J Immunol. 2013 Mar 15;190(6):2501-9
references.pmid: 23396941
references.citation: J Immunol. 2003 Jul 1;171(1):22-6
references.pmid: 12816978
references.citation: PLoS Pathog. 2012;8(7):e1002805
references.pmid: 22807681
references.citation: Proc Natl Acad Sci U S A. 2008 May 6;105(18):6696-701
references.pmid: 18448674
references.citation: Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20509-13
references.pmid: 22135458
references.citation: Immunogenetics. 1999 Nov;50(3-4):213-9
references.pmid: 10602881
references.citation: EMBO J. 1999 Aug 2;18(15):4250-60
references.pmid: 10428963
references.citation: Trends Immunol. 2006 Aug;27(8):368-73
references.pmid: 16815756
references.citation: Eur J Immunol. 1998 Sep;28(9):2854-63
references.pmid: 9754572
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10160-5
references.pmid: 20439706
references.citation: J Exp Med. 1997 Apr 21;185(8):1523-8
references.pmid: 9126935
references.citation: Eur J Immunol. 1997 Feb;27(2):563-7
references.pmid: 9045931
references.citation: J Biol Chem. 2000 Aug 4;275(31):23700-6
references.pmid: 10816589
references.citation: PLoS One. 2010 Dec 03;5(12):e15184
references.pmid: 21151939
references.citation: J Immunol. 2013 Mar 15;190(6):2924-30
references.pmid: 23382564
references.citation: Cell Host Microbe. 2012 Oct 18;12(4):470-83
references.pmid: 23084916
references.citation: Tissue Antigens. 1998 Oct;52(4):368-73
references.pmid: 9820600
references.citation: J Immunol. 2010 Dec 1;185(11):6728-33
references.pmid: 21048111
references.citation: J Immunol. 2005 Mar 1;174(5):2878-84
references.pmid: 15728498
references.citation: J Exp Med. 2008 Mar 17;205(3):725-35
references.pmid: 18332182
references.citation: J Immunol. 1998 May 1;160(9):4375-85
references.pmid: 9574542
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1734-9
references.pmid: 11172020
references.citation: Nat Rev Immunol. 2007 Apr;7(4):279-91
references.pmid: 17380157
references.citation: Cell. 1994 Nov 18;79(4):649-58
references.pmid: 7525079
references.citation: J Exp Med. 1998 Mar 2;187(5):813-8
references.pmid: 9480992
references.citation: Autoimmun Rev. 2012 Jul;11(9):627-35
references.pmid: 22100331
references.citation: Annu Rev Immunol. 2013;31:227-58
references.pmid: 23516982